Search - tctmd.com

Displaying 361 - 380 of 406

Sort: Relevancy | Date

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

News Daily News

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

September 12, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Daily News

Un Meta Análisis Estudia Indirectamente a las Diferencias Existentes entre Nuevos Anticoagulantes

September 11, 2012

News Daily News

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

September 11, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Yael L. Maxwell

August 29, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

Tras la transfusión TAVR Atado a una Mayor Mortalidad

August 16, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Comparativas Indirectas revelan que hay Pocas Diferencias entre Nuevos Anticoagulantes

August 14, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

L.A. McKeown

August 09, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

Jason Kahn

June 22, 2012

News Daily News

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Jason Kahn

June 22, 2012

Advertisement

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

Dabigatran Usage up, Both for A-fib and Off-Label Indications

Un Meta Análisis Estudia Indirectamente a las Diferencias Existentes entre Nuevos Anticoagulantes

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Tras la transfusión TAVR Atado a una Mayor Mortalidad

Post-TAVR Transfusion Tied to Increased Mortality

Indirect Comparisons Show Little Difference Among New Anticoagulants

Comparativas Indirectas revelan que hay Pocas Diferencias entre Nuevos Anticoagulantes

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content